Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Gibson

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
The Journal of Allergy and Clinical Immunology|May 23, 2020
Cross-reactivity between vancomycin, teicoplanin, and telavancin in patients with HLA-A∗32:01-positive vancomycin-induced DRESS sharing an HLA class II haplotypeNontaya Nakkam, Andrew Gibson, Effie Mouhtouris, et al.
Frontiers in Genetics|July 5, 2021
Visual Genomics Analysis Studio as a Tool to Analyze Multiomic DataRebecca J Hertzman, Pooja Deshpande, Shay Leary, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2017
The Effect of Inhibitory Signals on the Priming of Drug Hapten-Specific T Cells That Express Distinct Vβ ReceptorsAndrew Gibson, Lee Faulkner, Maike Lichtenfels, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 4, 2024
Glycolysis: An early marker for vancomycin-specific T-cell activationJoshua Gardner, Sean Hammond, Rebecca Jensen, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 3, 2023
A blinded in vitro analysis of the intrinsic immunogenicity of hepatotoxic drugs: implications for preclinical risk assessmentMonday O Ogese, Adam Lister, Liam Farrell, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 1, 2021
Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine HypersensitivitySean Hammond, Anna Olsson-Brown, Sophie Grice, et al.
Hepatology (Baltimore, Md.)|September 19, 2012
Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injuryManal M Monshi, Lee Faulkner, Andrew Gibson, et al.
Trials|April 4, 2018
Assessing the effectiveness of Enhanced Psychological Care for patients with depressive symptoms attending cardiac rehabilitation compared with treatment as usual (CADENCE): a pilot cluster randomised controlled trialSuzanne H Richards, Chris Dickens, Rob Anderson, et al.
The Journal of Allergy and Clinical Immunology. Global|February 26, 2025
Single-cell immunopathology of recurrent acute generalized exanthematous pustulosis associated with vancomycinEric M Mukherjee, Andrew Gibson, Matthew S Krantz, et al.
BMJ Open|October 6, 2018
General practitioners and emergency departments (GPED)-efficient models of care: a mixed-methods study protocolKatherine Morton, Sarah Voss, Joy Adamson, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
The Journal of Allergy and Clinical Immunology|May 23, 2020
Cross-reactivity between vancomycin, teicoplanin, and telavancin in patients with HLA-A∗32:01-positive vancomycin-induced DRESS sharing an HLA class II haplotypeNontaya Nakkam, Andrew Gibson, Effie Mouhtouris, et al.
Frontiers in Genetics|July 5, 2021
Visual Genomics Analysis Studio as a Tool to Analyze Multiomic DataRebecca J Hertzman, Pooja Deshpande, Shay Leary, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2017
The Effect of Inhibitory Signals on the Priming of Drug Hapten-Specific T Cells That Express Distinct Vβ ReceptorsAndrew Gibson, Lee Faulkner, Maike Lichtenfels, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 4, 2024
Glycolysis: An early marker for vancomycin-specific T-cell activationJoshua Gardner, Sean Hammond, Rebecca Jensen, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 3, 2023
A blinded in vitro analysis of the intrinsic immunogenicity of hepatotoxic drugs: implications for preclinical risk assessmentMonday O Ogese, Adam Lister, Liam Farrell, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 1, 2021
Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine HypersensitivitySean Hammond, Anna Olsson-Brown, Sophie Grice, et al.
Hepatology (Baltimore, Md.)|September 19, 2012
Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injuryManal M Monshi, Lee Faulkner, Andrew Gibson, et al.
Trials|April 4, 2018
Assessing the effectiveness of Enhanced Psychological Care for patients with depressive symptoms attending cardiac rehabilitation compared with treatment as usual (CADENCE): a pilot cluster randomised controlled trialSuzanne H Richards, Chris Dickens, Rob Anderson, et al.
The Journal of Allergy and Clinical Immunology. Global|February 26, 2025
Single-cell immunopathology of recurrent acute generalized exanthematous pustulosis associated with vancomycinEric M Mukherjee, Andrew Gibson, Matthew S Krantz, et al.
BMJ Open|October 6, 2018
General practitioners and emergency departments (GPED)-efficient models of care: a mixed-methods study protocolKatherine Morton, Sarah Voss, Joy Adamson, et al.
Pageof 11